Latest Innovation News

First Graphene has secured key patents for its Kainos Technology in Australia and Korea, positioning itself at the forefront of producing graphite, graphene, and hydrogen from petroleum waste. This milestone aligns with growing global demand for critical minerals essential to the energy transition.

Telix Pharmaceuticals has finalized its acquisition of RLS (USA) Inc., significantly expanding its radiopharmaceutical footprint across the United States with a network of over 30 radiopharmacies.

Kincora Copper Limited has unveiled an updated investor presentation outlining its aggressive push towards Tier-1 copper-gold discoveries, backed by over $60 million in partner funding and ramped-up drilling programs across New South Wales and Mongolia.

Complii FinTech Solutions Ltd reports a robust Q2 FY25 with a $3.048 million cash balance, a net operational cash inflow, and a 12.9% year-on-year increase in Annual Recurring Revenue, driven by strategic divestment and focused growth initiatives.

Veris Limited has reported a remarkable 212% increase in profit before tax for H1 FY25, driven by a strategic pivot towards higher-margin projects and successful restructuring efforts. Despite a slight revenue dip, the company’s strong order book and cash position signal robust growth potential.

Zelira Therapeutics has received a fourth funding tranche, bringing total investment to US$3.25 million to support FDA clinical trials of its HOPE® 1 cannabinoid medicine targeting irritability in autism spectrum disorder and Phelan-McDermid Syndrome.

Swift Networks reports steady cash flow and contract wins in mining and aged care, while unveiling a new feature to capitalize on upcoming aged care legislation.

Oneview Healthcare reported a robust Q4 2024 cash flow update, bolstered by a significant equity raise and expanding partnerships, positioning the company for accelerated growth in 2025.

InhaleRx has corrected its quarterly report and revealed a $38.5 million funding deal to fast-track clinical trials for its inhaled therapies targeting breakthrough cancer pain and panic disorder, aiming for FDA approval.

K-TIG Limited is set to transform its business with a $7–10 million capital raise to acquire US-based Metal Powder Works, issuing performance-based vendor shares that an independent expert deems fair and reasonable.

Phoslock Environmental Technologies reported a widening cashflow deficit and disappointing sales in the December 2024 quarter, while legal challenges and share suspension continue to cloud its outlook.

Gathid Ltd reports a strong quarter with a 92% year-on-year increase in Annual Recurring Revenue, new customer wins, and industry recognition, despite ongoing challenges in finalising the sale of its physical security business.